Stock listing
Genomtec Sa
Selected listing: GMT · GPW · PLN · PL
Genomtec Sa (GPW:GMT), Health Technology. Latest release Jun 1, 2026: GMT: Net loss narrowed and revenue rose, but continued funding and market risks persist.
- Ticker
- GPW:GMT
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- GPW
- Currency
- PLN
About Genomtec Sa
Genomtec SA is a public company listed on the Polish market under the ticker GMT. Genomtec focuses on developing innovative solutions in the field of molecular diagnostics.
Latest news from Genomtec Sa
GMT: Net loss narrowed and revenue rose, but continued funding and market risks persist
June 1, 2026
GMT: Patent expansion, cost cuts, and narrowed loss set the stage for commercialization in 2026
April 30, 2026
GMT: Net loss persists as R&D spending rises; commercialization and funding remain critical
November 28, 2025
GMT: Net loss deepened to PLN 6.6M as R&D spending rose; commercialization still ahead
September 29, 2025
GMT: Genomtec's Q1 2025 loss widened as R&D ramped up, with commercialization still pending
May 29, 2025